BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20172413)

  • 21. Chemokines in the pathogenesis of vascular disease.
    Charo IF; Taubman MB
    Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 18 and cardiovascular disease in HIV-1 infection: a partner in crime?
    Torre D; Pugliese A
    AIDS Rev; 2010; 12(1):31-9. PubMed ID: 20216908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus.
    Beltrán LM; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; García-Puig J; Moreno JA
    Vasc Health Risk Manag; 2015; 11():35-48. PubMed ID: 25609975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.
    Kline ER; Sutliff RL
    J Investig Med; 2008 Jun; 56(5):752-69. PubMed ID: 18525451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons.
    Teofili L; Iachininoto MG; Capodimonti S; Ucciferri C; Nuzzolo ER; Martini M; Torti L; Falasca K; Vecchiet J; Leone G; Larocca LM
    AIDS; 2010 Oct; 24(16):2443-50. PubMed ID: 20827169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction in HIV infection.
    Cotter BR
    Curr HIV/AIDS Rep; 2006 Sep; 3(3):126-31. PubMed ID: 16970839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.
    Wang T; Yi R; Green LA; Chelvanambi S; Seimetz M; Clauss M
    Cardiovasc Pathol; 2015; 24(5):279-82. PubMed ID: 26233281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Controversies regarding the pathogenesis of cardiovascular diseases in HIV patients].
    Barelli S; Angelillo-Scherrer A; Foguena AK; Periard D; Cavassini M
    Rev Med Suisse; 2011 Apr; 7(292):905-10. PubMed ID: 21674894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease, inflammation, and periodontal infection.
    Paquette DW; Brodala N; Nichols TC
    Periodontol 2000; 2007; 44():113-26. PubMed ID: 17474929
    [No Abstract]   [Full Text] [Related]  

  • 30. Inflammation in atherosclerosis: a cause or a result of vascular disorders?
    Manduteanu I; Simionescu M
    J Cell Mol Med; 2012 Sep; 16(9):1978-90. PubMed ID: 22348535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.
    Sviridov D; Mukhamedova N; Makarov AA; Adzhubei A; Bukrinsky M
    AIDS; 2020 Jan; 34(1):1-13. PubMed ID: 31789888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice.
    Pillay B; Ramdial PK; Naidoo DP
    Cardiovasc J Afr; 2015; 26(2):70-81. PubMed ID: 25940120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Features of Monocytes and Macrophages in Cardiovascular Biology and Disease.
    van der Vorst EPC; Weber C
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e30-e37. PubMed ID: 30673349
    [No Abstract]   [Full Text] [Related]  

  • 34. Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation-Thrombosis Axis.
    McCutcheon K; Manga P
    Thromb Haemost; 2022 Apr; 122(4):476-479. PubMed ID: 34689321
    [No Abstract]   [Full Text] [Related]  

  • 35. [Research progress on dyslipidemia related to human immunodeficiency virus infection].
    Li L; Ma P
    Zhonghua Nei Ke Za Zhi; 2024 Mar; 63(3):303-309. PubMed ID: 38448194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physiopathology of cholesterol].
    MOIA B
    Rev Asoc Med Argent; 1962 Jan; 76():7-18. PubMed ID: 14475096
    [No Abstract]   [Full Text] [Related]  

  • 37. Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.
    Menter DG; Afshar-Kharghan V; Shen JP; Martch SL; Maitra A; Kopetz S; Honn KV; Sood AK
    Cancer Metastasis Rev; 2022 Mar; 41(1):147-172. PubMed ID: 35022962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physiopathology of cardiovascular disease in HIV-infected patients].
    Alonso-Villaverde Lozano C
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():33-9. PubMed ID: 20172413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune factors in atherosclerosis].
    Pasqui AL; Bova G; Maffei S; Auteri A
    Ann Ital Med Int; 2005; 20(2):81-9. PubMed ID: 16052840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.